Table 1.

Characteristics of patient cohort

CharacteristicValue
Age (yr)25.5±5.9
Men (%)97.5
African Americans (%)7.9
Median ISS (IQR)9 (1–24)
Median TBSA (IQR) (%)9 (4–24)
Median FT TBSA (IQR) (%)1 (0–13.75)
Median ventilator days (IQR)0 (0–4)
Median ICU days (IQR)0 (0–10.5)
Median hospital days (IQR)12 (6-35.5)
Inhalation injury (%)16.6
Renal replacement therapy (%)5.9
Mortality rate (%)5.9
Admission creatinine in patients with AKIa (mg/dl)1.24±0.82
Admission creatinine in patients without AKIa (mg/dl)0.89±0.15
Admission eGFR in patients with AKIa by CKD-EPI (ml/min per 1.73 m2)97±31
Admission eGFR in patients without AKIa by CKD-EPI (ml/min per 1.73 m2)116±16
Admission eGFR in patients with AKIa by MDRD (ml/min per 1.73 m2)89±32
Admission eGFR in patients without AKIa by MDRD (ml/min per 1.73 m2)109±24
Creatinine at AKIa (mg/dl)1.39±0.81
Peak creatinine in patients without AKIa (mg/dl)0.94±0.16
AKIN-1 peak creatinine (mg/dl)1.20±0.31
AKIN-2 peak creatinine (mg/dl)1.98±0.57
AKIN-3 peak creatinine (mg/dl)3.70±2.11
Median day of AKI diagnosisa (IQR)1 (1–4)
  • Data expressed with a plus/minus sign are the mean ± SD. ISS, Injury Severity Score; IQR, interquartile range; TBSA, percentage of total body surface area burned; FT TBSA, percentage of TBSA that is full thickness; eGFR, estimated GFR; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; MDRD, Modification of Diet in Renal Disease.

  • a As defined by the Acute Kidney Injury Network criteria.